Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Trimetazidine on Endothelin-1 and Clinical Outcomes of Patients With Diabetic Peripheral Neuropathy

NCT07794475 is registered in ClinicalTrials.gov with Sara Refaat Azab Metry as lead sponsor.

NCT NCT07794475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07794475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Trimetazidine on Endothelin-1 and Clinical Outcomes of Patients With Diabetic Peripheral Neuropathy
Lead sponsor
Sara Refaat Azab Metry
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 1, 2026
Completion date
February 28, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain (dpn)